Catalys Pacific, Llc Portfolio Stock Holdings

Catalys Pacific, Llc disclosed 2 stock positions valued at approximately $230.7 million in its latest SEC 13F filing. The largest holdings include Mineralys Therapeutics, Inc. and Phathom Pharmaceuticals, Inc.. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.

Report Period
March 31, 2026
No. of Stocks
2
Portfolio Value
$230.7M
Holdings by Sector
Catalys Pacific, Llc Portfolio Holdings in Q1 2026

2 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
Mineralys Therapeutics, Inc.MLYSHealthcare92.81%7,903,838--$214,114,971
Phathom Pharmaceuticals, Inc.PHATHealthcare7.19%1,493,854+64,840+4.54%$16,596,718